EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC 4.0

Pathotype-Specific Expression of Granzyme-Perforin Pathway Genes and Their Association With Clinical Disease Activity in Early Rheumatoid Arthritis and in a Randomized Clinical Trial

Francisco G La Rosa iD, Larry W Moreland iD, Luigi Nibali iD, Mike Curtis iD, Kevin D Deane iD, Colin Strickland iD, Jennifer Seifert iD, Carson Keeter iD, Dmitri Simberg iD, Robert I Scheinman iD, Rachel Lau iD, Costantino Pitzalis iD und 4 weitere

Immune Network · 2025 · 25 (4)

DOI: 10.4110/in.2025.25.e25 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Immune Network, 2025. Verfasst von Francisco G La Rosa und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, School of Medicine, University of Colorado, Anschutz Medical Campus, Aurora, CO 80045, USA. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rheumatoid arthritis (RA) is an autoimmune disease. We examined gene expression of five granzymes (GZMs), perforin (PRF-1), and serglycin (SRGN) from tissues derived from pathobiology of early arthritis cohort (PEAC) and phase 4 randomized controlled trial in anti-TNF inadequate responder patients with RA (R4RA). Information regarding gene expression of GZMs, PRF-1, and SRGN in synovium and blood pathotypes and their correlations with disease activity scores with 28 joints (DAS28)-erythrocyte sedimentation rate and with DAS28-C-reactive protein in early RA (eRA) is lacking. To determine the expression of these genes in synovium and blood pathotypes, we analyzed bulk RNA-sequencing data. The percentage of CD8+ T cells was determined in synovium, and the presence of Porphyromonas gingivalis was examined in synovium. The expression of GZM A, B, H, K, M, PRF-1, and SRGN was significantly higher in the lymphoid pathotype in the PEAC and R4RA synovium. The percentage of CD8 T cells was low, and minor speckles (Ag-reactivity) of P. gingivalis Ag were detected in eRA synovium. Rituximab and tocilizumab treatment in R4RA decreased the expression of all GZMs, PRF-1, and SRGN in the synovium. In conclusion, components of the GZM-PRF-1 pathway are upregulated in RA and may play a mechanistic role.

Schlagwörter

Stichwörter der Autor:innen

Bulk RNA-seqEarly rheumatoid arthritisGranzymesPerforinSerglycinSynovium

Autor:innen und Institutionen

  • Department of Pathology, School of Medicine, University of Colorado, Anschutz Medical Campus, Aurora, CO 80045, USA.
  • Division of Rheumatology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
  • Centre for Host-Microbiome Interactions, Faculty of Dentistry, Oral & Craniofacial Sciences, King's College London Guy's Hospital, London SE1 9RT, UK.
  • Department of Radiology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
  • Department of Orthopedics and the Colorado Program for Musculoskeletal Research, University of Colorado, Anschutz Medical Campus, Aurora, CO 80045, USA.
  • Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Anschutz Medical Campus, CO 80045, USA.

ORCID-Profile: Francisco G La Rosa, Larry W Moreland, Luigi Nibali, Mike Curtis, Kevin D Deane, Colin Strickland, Jennifer Seifert, Carson Keeter, Dmitri Simberg, Robert I Scheinman, Rachel Lau, Costantino Pitzalis, Myles J Lewis, V Michael Holers, Nirmal K Banda

Förderung

  • NIAID NIH HHS

Zitieren

APA

La Rosa, F. G., Moreland, L. W., Nibali, L., Curtis, M., Deane, K. D., Strickland, C., Seifert, J., Keeter, C., Simberg, D., Scheinman, R. I., Lau, R., Pitzalis, C., Lewis, M. J., Holers, V. M., Banda, N. K., & Accelerating Medicines Partnership RA/SLE Network (2025). Pathotype-Specific Expression of Granzyme-Perforin Pathway Genes and Their Association With Clinical Disease Activity in Early Rheumatoid Arthritis and in a Randomized Clinical Trial. Immune Network, 25(4). https://doi.org/10.4110/in.2025.25.e25

Vancouver

La Rosa FG, Moreland LW, Nibali L, Curtis M, Deane KD, Strickland C, et al. Pathotype-Specific Expression of Granzyme-Perforin Pathway Genes and Their Association With Clinical Disease Activity in Early Rheumatoid Arthritis and in a Randomized Clinical Trial. Immune Network. 2025;25(4). doi:10.4110/in.2025.25.e25

BibTeX
@article{LaRosa2025,
  author = {La Rosa, Francisco G and Moreland, Larry W and Nibali, Luigi and Curtis, Mike and Deane, Kevin D and Strickland, Colin and Seifert, Jennifer and Keeter, Carson and Simberg, Dmitri and Scheinman, Robert I and Lau, Rachel and Pitzalis, Costantino and Lewis, Myles J and Holers, V Michael and Banda, Nirmal K and Accelerating Medicines Partnership RA/SLE Network, Accelerating Medicines Partnership RA/SLE Network},
  title = {Pathotype-Specific Expression of Granzyme-Perforin Pathway Genes and Their Association With Clinical Disease Activity in Early Rheumatoid Arthritis and in a Randomized Clinical Trial},
  journal = {Immune Network},
  year = {2025},
  volume = {25},
  number = {4},
  doi = {10.4110/in.2025.25.e25}
}
Kostenlos starten →